What To Watch As FDA Begins To Fight Rising Drug Prices
With the enactment of the Hatch-Waxman Act, Congress spurred generic competitors to enter the market and lower the cost of expensive, brand-name pharmaceuticals. At the same time, to incentivize new drug...To view the full article, register now.
Already a subscriber? Click here to view full article